Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab-Berbers

被引：1
|
作者：
Follett, Jordan [1 ]
Guenther, Dylan [1 ]
Xoi, Leyna [1 ]
Amouri, Rim [2 ]
Ben Sassi, Samia [2 ]
Hentati, Faycel [2 ]
Farrer, Matthew J. [1 ,3 ]
机构：
[1] Univ Florida, Dept Neurol, Gainesville, FL 32610 USA
[2] Mongi Ben Hamida Natl Inst Neurol, La Rabta, Tunisia
[3] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32610 USA
来源：
MOVEMENT DISORDERS | 2024年 / 39卷 / 04期
关键词：
PENETRANCE; MUTATION;
D O I：
10.1002/mds.29735
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：751 / 753
页数：3
相关论文
共 50 条
  • [31] The Cell Biology of LRRK2 in Parkinson's Disease
    Usmani, Ahsan
    Shavarebi, Farbod
    Hiniker, Annie
    MOLECULAR AND CELLULAR BIOLOGY, 2021, 41 (05)
  • [32] LRRK2 is reduced in Parkinson's disease gut
    de Guilhem de Lataillade, Adrien
    Verchere, Jeremy
    Oullier, Thibauld
    Prigent, Alice
    Durand, Tony
    Pellegrini, Carolina
    Neunlist, Michel
    Baron, Thierry
    Rolli-Derkinderen, Malvyne
    Derkinderen, Pascal
    ACTA NEUROPATHOLOGICA, 2021, 142 (03) : 601 - 603
  • [33] Lrrk2 pathogenic substitutions in Parkinson's disease
    Mata, IF
    Kachergus, JM
    Taylor, JP
    Lincoln, S
    Aasly, J
    Lynch, T
    Hulihan, MM
    Cobb, SA
    Wu, RM
    Lu, CS
    Lahoz, C
    Wszolek, ZK
    Farrer, MJ
    NEUROGENETICS, 2005, 6 (04) : 171 - 177
  • [34] Lrrk2 pathogenic substitutions in Parkinson's disease
    Ignacio F. Mata
    Jennifer M. Kachergus
    Julie P. Taylor
    Sarah Lincoln
    Jan Aasly
    Timothy Lynch
    Mary M. Hulihan
    Stephanie A. Cobb
    Ruey-Meei Wu
    Chin-Song Lu
    Carlos Lahoz
    Zbigniew K. Wszolek
    Matthew J. Farrer
    Neurogenetics, 2005, 6 : 171 - 177
  • [35] LRRK2 as a therapeutic target in Parkinson's disease
    Tan, E. K.
    Schapira, A. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (04) : 545 - 546
  • [36] Targeting LRRK2 mutations in Parkinson's disease
    Lesniak, Robert K.
    Nichols, Robert Jeremy
    Smith, Mark
    Montine, Thomas J.
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (16) : 1167 - 1170
  • [37] LRRK2 and the Endolysosomal System in Parkinson's Disease
    Erb, Madalynn L.
    Moore, Darren J.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1271 - 1291
  • [38] LRRK2 in Parkinson's disease: biochemical functions
    Anand, Vasanti S.
    Braithwaite, Steven P.
    FEBS JOURNAL, 2009, 276 (22) : 6428 - 6435
  • [39] Pathological Functions of LRRK2 in Parkinson's Disease
    Jeong, Ga Ram
    Lee, Byoung Dae
    CELLS, 2020, 9 (12) : 1 - 19
  • [40] LRRK2 activation in idiopathic Parkinson's disease
    Di Maio, Roberto
    Hoffman, Eric K.
    Rocha, Emily M.
    Keeney, Matthew T.
    Sanders, Laurie H.
    De Miranda, Briana R.
    Zharikov, Alevtina
    Van Laar, Amber
    Stepan, Antonia F.
    Lanz, Thomas A.
    Kofler, Julia K.
    Burton, Edward A.
    Alessi, Dario R.
    Hastings, Teresa G.
    Greenamyre, J. Timothy
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)
12345